Am J Clin Pathol

1. SUMRANSUB N, Bachanova V, Linden MA
   Kikuchi-Fujimoto disease mimicking T-cell lymphoma after COVID-19 vaccination.
   Am J Clin Pathol. 2024 Mar 9:aqae016. doi: 10.1093.
   

   >> Share

   
   

   
   Am J Surg Pathol

2. KURASHIGE R, Kurashige M, Okada Y, Higuchi K, et al
   Differentiating Between Epstein-Barr Virus-positive Lymphoid Neoplasm Relapse and Post-transplant Lymphoproliferative Disorder After Sex-mismatched Hematopoietic Stem Cell Transplantation.
   Am J Surg Pathol. 2024;48:395-405.
   

   >> Share

   
   

   
   Blood

3. GODFREY JK, Gao L, Shouse G, Song JY, et al
   Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma.
   Blood. 2024 Mar 14:blood.2024024168. doi: 10.1182/blood.2024024168.
   

   >> Share

   
   
4. MOLIN D
   Aging Kairos: treating older Hodgkin patients.
   Blood. 2024;143:943-945.
   

   >> Share

   
   
5. EL HUSSEIN S
   Monomorphic epitheliotropic T-cell lymphoma with strong CD4 expression.
   Blood. 2024;143:1055.
   

   >> Share

   
   

   
   Br J Haematol

6. MANOS K, Churilov L, Grigg A, Di Ciaccio P, et al
   Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance study.
   Br J Haematol. 2024 Mar 14. doi: 10.1111/bjh.19407.
   

   >> Share

   
   
7. BAPTISTA P, Aguiar E, Fonseca E, Pinto R, et al
   Intravascular large B-cell lymphoma presenting with haemophagocytic syndrome.
   Br J Haematol. 2024 Mar 12. doi: 10.1111/bjh.19350.
   

   >> Share

   
   
8. NGUYEN PC, Nguyen T, Wilson C, Tiong IS, et al
   Evaluation of T-cell clonality by anti-TRBC1 antibody-based flow cytometry and correlation with T-cell receptor sequencing.
   Br J Haematol. 2024;204:910-920.
   

   >> Share

   
   
9. AL-MASHHADI AL, Jakobsen LH, Brown P, Gang AO, et al
   Real-world outcomes following third or subsequent lines of therapy: A Danish population-based study on 189 patients with relapsed/refractory large B-cell lymphomas.
   Br J Haematol. 2024;204:839-848.
   

   >> Share

   
   

   
   Hum Pathol

10. KIM DH, Siddiqui S, Jain P, Wang M, et al
    TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are present.
    Hum Pathol. 2024;146:1-7.
    

    >> Share

    
    

    
    Int J Cancer

11. FEDELI U, Barbiellini Amidei C, Han X, Jemal A, et al
    Changes in mortality associated with different hematologic malignancies during the pandemic in the United States.
    Int J Cancer. 2024;154:1703-1708.
    

    >> Share

    
    

    
    Leuk Lymphoma

12. RAMALINGAM TR
    Flow cytometry is a sensitive technique to assess marrow involvement by B cell non-Hodgkins lymphoma.
    Leuk Lymphoma. 2024 Mar 14:1-2. doi: 10.1080/10428194.2024.2330707.
    

    >> Share

    
    
13. GORDON MJ, Dubois S, Bryant B, Ng S, et al
    A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma.
    Leuk Lymphoma. 2024 Mar 9:1-4. doi: 10.1080/10428194.2024.2326847.
    

    >> Share

    
    

    
    Mod Pathol

14. BATAI B, Kiss L, Varga L, Nagy A, et al
    Profiling of copy number alterations using low-coverage whole-genome sequencing informs differential diagnosis and prognosis in primary cutaneous follicle center lymphoma.
    Mod Pathol. 2024 Mar 7:100465. doi: 10.1016/j.modpat.2024.100465.
    

    >> Share

    
    

    
    PLoS One

15. YU N, Zhang W, Zhong X, Song X, et al
    Incidence and survival of second primary non-Hodgkin lymphoma: A Surveillance, Epidemiology, and End Results-based cohort study.
    PLoS One. 2024;19:e0300330.
    

    >> Share

    
    
16. HESSELING PB, Afungchwi GM, Njodzeka BW, Wharin P, et al
    Burkitt lymphoma: The effect of age, sex and delay to diagnosis on treatment completion and outcome of treatment in 934 Patients in Cameroon.
    PLoS One. 2024;19:e0299777.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share